The laser surgery that puts heartbeat back on track in an HOUR
More than one million Britons have a heart rhythm problem known as atrial fibrillation. Diana Jackson, 68, from Arnside, Cumbria, underwent a new laser procedure to treat it. (Source: the Mail online | Health)
Source: the Mail online | Health - January 18, 2021 Category: Consumer Health News Source Type: news

Left Atrial Appendage Occlusion, DOAC Comparable for AFib Left Atrial Appendage Occlusion, DOAC Comparable for AFib
Left atrial appendage occlusion for high-risk atrial fibrillation prevents stroke as well as direct oral anticoagulation, with a lower risk of major bleeding, according to a European study.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 14, 2021 Category: Cardiology Tags: Cardiology News Source Type: news

Calcium-Induced Autonomic Denervation Linked to Lower Post-op AF Calcium-Induced Autonomic Denervation Linked to Lower Post-op AF
Intraoperative injection of calcium chloride into the four major atrial ganglionated plexi reduced the incidence of early postoperative atrial fibrillation in a proof-of-concept study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 14, 2021 Category: Consumer Health News Tags: Cardiology News Source Type: news

Even 1 Drink a Day May Raise Your Odds for A-Fib
THURSDAY, Jan. 14, 2021 -- Moderate drinking is often touted as heart-healthy, but a large new study finds that even one drink a day might raise the risk of an abnormal heart rhythm called atrial fibrillation. Atrial fibrillation, or a-fib, is a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - January 14, 2021 Category: General Medicine Source Type: news

Consuming Alcohol May Increase Risk for Atrial Fibrillation
WEDNESDAY, Jan. 13, 2021 -- Alcohol consumption, even at a level of one drink per day, is associated with an increased risk for atrial fibrillation (AF), according to a study published online Jan. 12 in the European Heart Journal. Dora Csengeri,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 13, 2021 Category: Pharmaceuticals Source Type: news

ECG Challenge:'I'm Having Trouble Breathing'ECG Challenge:'I'm Having Trouble Breathing '
A man taking amiodarone for his atrial fibrillation feels increasingly short of breath and visits the emergency department. What's the diagnosis?Medscape Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 4, 2021 Category: Consumer Health News Tags: Cardiology Clinical Case Source Type: news

Oral Anticoagulants for Atrial Fibrillation: Benefits Outweigh Risks for Older Adults
Atrial fibrillation (AF) causes one in seven strokes overall, and one in four strokes in people over the age of 80, according to the National Institutes of Health — which makes stroke prevention a pillar of AF management. Yet oral anticoagulation (OAC), which reduces the risk of stroke by one-half to two-thirds in people with AF, is underutilized in the assisted living and long-term care population. (Source: Caring for the Ages)
Source: Caring for the Ages - December 29, 2020 Category: Health Management Authors: Christine Kilgore Source Type: news

In This Issue
Benefits of oral anticoagulants for atrial fibrillation outweigh their risks for older adults. 7 (Source: Caring for the Ages)
Source: Caring for the Ages - December 29, 2020 Category: Health Management Source Type: news

ACC/AHA Update Two Atrial Fibrillation Performance Measures ACC/AHA Update Two Atrial Fibrillation Performance Measures
The changes clarify the definition of atrial fibrillation and separate CHA2DS2-VASc risk score treatment thresholds for men and women; both are in line with 2019 guideline changes.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - December 10, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Heavy Alcohol Consumption Tied to Worse Atrial Fibrillation Outcomes
TUESDAY, Dec. 8, 2020 -- Heavy alcohol consumption increases the risk of adverse events in patients with atrial fibrillation (AF), according to a study published online Nov. 23 in EP Europace. Chewan Lim, from the Yonsei University College of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 8, 2020 Category: Pharmaceuticals Source Type: news

New Data Demonstrate Long-Term Benefit of IMBRUVICA ® (ibrutinib) as First-Line Treatment for High-Risk Chronic Lymphocytic Leukemia
This study highlighted the need for cytogenetic/molecular testing before CIT treatment, consistent with clinical treatment guidelines.[8],[9]Real-World Prognostic Biomarker Testing, Treatment Patterns, And Dosing Among Patients With CLL/SLL From the informCLL™ Prospective Observational Registry (Abstract #547)An oral presentation on Monday, December 7, will feature results from the informCLL™ real-world prospective observational registry assessing treatment patterns in the era of novel agents.4 Key Study Findings:· The most common index treatment was IMBRUVICA®; the majority of patients treated with ...
Source: Johnson and Johnson - December 6, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Disease-Free Survival Data from CAPTIVATE Study Demonstrate Benefit of IMBRUVICA ® (ibrutinib)-Based Regimen as Fixed Duration, First-Line Treatment for Patients with Chronic Lymphocytic Leukemia
December 5, 2020 (RARITAN, N.J.) – New data from the Phase 2 CAPTIVATE study were presented today during an oral session at the 2020 American Society of Hematology (ASH) Annual Meeting (Abstract #123). The study evaluated the efficacy and safety of IMBRUVICA® (ibrutinib) plus venetoclax in the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and showed that, after achieving undetectable minimal residual disease (uMRD) in both the blood and bone marrow with the IMBRUVICA® combination regimen, the one-year disease-free survival (DFS) of patients randomized ...
Source: Johnson and Johnson - December 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

Patients with heart rhythm disorder warned against heavy alcohol consumption
(European Society of Cardiology) Fourteen drinks a week is linked with a higher risk of health problems including stroke and embolism in patients with atrial fibrillation, according to research published in EP Europace, a journal of the European Society of Cardiology (ESC). " Our study suggests that atrial fibrillation patients should avoid heavy alcohol consumption to prevent stroke and other complications, " said author Dr. Boyoung Joung of Yonsei University College of Medicine, Seoul, Republic of Korea. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - December 2, 2020 Category: International Medicine & Public Health Source Type: news

Ongoing anticoagulant treatment does not seem to protect against severe COVID-19
(Karolinska Institutet) DOAC (direct oral anticoagulant) pills are used in the treatment of atrial fibrillation by preventing blood clots. Even though blood clots are thought to contribute to complications from the new coronavirus infection, users of this class of drug do not seem to be protected against severe COVID-19, reports a large Swedish registry study from Karolinska Institutet published in The Journal of Internal Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2020 Category: International Medicine & Public Health Source Type: news

Differences Between AF and Atrial Flutter in Atrial Remodeling Differences Between AF and Atrial Flutter in Atrial Remodeling
Atrial fibrillation and atrial flutter share many similarities, but a new study shows they are very different when it comes to atrial remodeling.Journal of the American College of Cardiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 27, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

AHA: Ablation Better Than Meds for Initial A-Fib Treatment
WEDNESDAY, Nov. 25, 2020 -- Cryoballoon ablation is superior to drug therapy as an initial treatment for the prevention of atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation, according to a study published online Nov. 16 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 25, 2020 Category: Pharmaceuticals Source Type: news

Fitbit Receives FDA Approval for a Wearable Device App That Detects Atrial Fibrillation
Many companies want to adapt consumer wearables to monitor health conditions, including biomarkers tested by medical laboratories Clinical laboratory managers know that wearable devices for monitoring biophysical functions or measuring biomarkers are becoming more complex and capable thanks to advances in miniaturization, informatics, software, and artificial intelligence machine learning that enable new functions to be […] The post Fitbit Receives FDA Approval for a Wearable Device App That Detects Atrial Fibrillation appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - November 25, 2020 Category: Laboratory Medicine Authors: Jude Tags: Compliance, Legal, and Malpractice Instruments & Equipment Laboratory Instruments & Laboratory Equipment Laboratory Management and Operations Laboratory News Laboratory Operations Laboratory Pathology Laboratory Testing Management & Operat Source Type: news

ECG Increases AF Detection, but Not Anticoagulation, After Stroke ECG Increases AF Detection, but Not Anticoagulation, After Stroke
Researchers suggest that additional ECG monitoring should be focused on patients with stroke who are at increased risk of atrial fibrillation.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 25, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Atrial Fibrillation (AFib) Symptoms and Signs
Title: Atrial Fibrillation (AFib) Symptoms and SignsCategory: Diseases and ConditionsCreated: 6/16/2016 12:00:00 AMLast Editorial Review: 11/20/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 20, 2020 Category: Cardiology Source Type: news

New-Onset AF Common But Unrecognized Early After Cardiac Surgery New-Onset AF Common But Unrecognized Early After Cardiac Surgery
One in five patients at elevated stroke risk who underwent cardiac surgery with no history of atrial fibrillation developed postoperative AF within the first 30 days after leaving hospital in the randomized SEARCH-AF trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 17, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

Is Ablation Rx the Best First Choice for A-Fib?
TUESDAY, Nov. 17, 2020 -- A procedure that freezes bits of heart tissue may be a better option than medication for people with atrial fibrillation (a-fib, or AF), two clinical trials have found. A-fib is a common heart arrhythmia in which the... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 17, 2020 Category: General Medicine Source Type: news

EARLY-AF and STOP AF Put Electrophysiology at a Crossroads EARLY-AF and STOP AF Put Electrophysiology at a Crossroads
Seemingly positive data on earlier use of catheter ablation in patients with atrial fibrillation concerns some electrophysiologists.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 17, 2020 Category: Cardiology Tags: Cardiology Expert Column Source Type: news

ACR: Warfarin Tied to Increased Risk for Knee, Hip Replacement in OA
MONDAY, Nov. 16, 2020 -- For adults with atrial fibrillation, warfarin is associated with an increased risk for knee and hip replacements for osteoarthritis (OA), according to a study presented at ACR Convergence, the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 16, 2020 Category: Pharmaceuticals Source Type: news

Study: Fish Oil Doesn ’ t Seem To Prevent Heart Problems
This study is consistent with earlier trials. The US Food and Drug Administration approved the fish oil-based drug Vascepa for heart attack and stroke prevention in 2019. Nissen hopes the FDA will take a look at these studies and reconsider that decision. “But it’s hard to get something undone once the genie gets out of the bottle,” he said. An editorial in the journal that accompanies the study written by Dr. Gregory Curfman, assistant professor of medicine at Harvard Medical School, also suggested the FDA should require a postmarketing clinical trial of a high-dose of fish oil, such as Vascepa, vs. corn...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 16, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN fish oil Source Type: news

Patients at risk of atrial fibrillation may need additional monitoring after heart surgery
(American Heart Association) There appears to be a high rate of unrecognized atrial fibrillation in the month following heart surgery among people who have an increased risk of stroke, even when atrial fibrillation was not detected immediately following surgery.When high-risk patients wore a heart monitor 24-hours a day for 30 days after heart surgery, atrial fibrillation was detected ten times more often than in patients who were not monitored continuously. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 16, 2020 Category: International Medicine & Public Health Source Type: news

Omega-3, Vit-D Both Fail at AF Primary Prevention in VITAL-Rhythm Omega-3, Vit-D Both Fail at AF Primary Prevention in VITAL-Rhythm
Neither supplement, here used as drugs, made a difference in risk for incident atrial fibrillation in the 5-year trial. And a secondary sensitivity analysis contained a cautionary signal.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news

Fish Oil, Vitamin D Supplements Won't Prevent A-Fib
Millions of people take a fish oil or vitamin D supplement in hopes of warding off a host of ills. But a new study finds the nutrients won't shield against the common and potential heart rhythm disorder known as atrial fibrillation. (Source: WebMD Health)
Source: WebMD Health - November 13, 2020 Category: Consumer Health News Source Type: news

What Is the Most Common Cause of Atrial Fibrillation (AFib, AF)?
Title: What Is the Most Common Cause of Atrial Fibrillation (AFib, AF)?Category: Diseases and ConditionsCreated: 11/13/2020 12:00:00 AMLast Editorial Review: 11/13/2020 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 13, 2020 Category: Cardiology Source Type: news

Fish oil and vitamin D supplements not effective for preventing atrial fibrillation
(American Heart Association) About 2.7 million Americans are living with atrial fibrillation, an irregular heartbeat that can lead to blood clots, strokes, heart failure and other heart-related complications.Previous studies have not been able to confirm if vitamin D and omega-3 fatty acid supplements such as fish oil can prevent atrial fibrillation, while some studies have conflicting data about the risks and benefits of these supplements for patients with other health conditions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2020 Category: International Medicine & Public Health Source Type: news

Study: Vitamin D, fish oil don't lower atrial fibrillation risk
(Cedars-Sinai Medical Center) New research presented today at the American Heart Association Scientific Sessions suggests neither vitamin D nor the omega-3 fatty acids found in fish oil prevent the development of atrial fibrillation, a potentially serious heart rhythm disturbance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2020 Category: International Medicine & Public Health Source Type: news

Cost-effectiveness of antithrombotic agents for atrial fibrillation in older adults at risk for falls: a mathematical modelling study - Wong EKC, Belza C, Naimark DMJ, Straus SE, Wijeysundera HC.
BACKGROUND: Antithrombotic drugs decrease stroke risk in patients with atrial fibrillation, but they increase bleeding risk, particularly in older adults at high risk for falls. We aimed to determine the most cost-effective antithrombotic therapy in older ... (Source: SafetyLit)
Source: SafetyLit - November 11, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Cryoballoon Supplement to Pulmonary Vein Isolation Curbs AF Recurrence Cryoballoon Supplement to Pulmonary Vein Isolation Curbs AF Recurrence
In patients with long-standing persistent recurrence of atrial fibrillation, pulmonary-vein isolation with concomitant left atrial posterior wall isolation using the cryoballoon suppresses AF recurrence more effectively than does PVI alone, according to US and Japanese researchers.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 11, 2020 Category: Surgery Tags: Cardiology News Source Type: news

New XARELTO ® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020
RARITAN, N.J., November 9, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses of XARELTO® (rivaroxaban) from the landmark VOYAGER PAD trial, part of the EXPLORER global cardiovascular research program, will be presented, including two live, featured science oral presentations. “We're pleased VOYAGER PAD was selected to be front and center once again at a major medical congress, as there's an urgent need f...
Source: Johnson and Johnson - November 9, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

AHA News: Fighting Fires Raises Risk for Irregular Heartbeat
MONDAY, Nov. 9, 2020 (American Heart Association News) -- Fighting fires comes with many risks. But new research shows there's a new one to consider: increased exposure to fires appears to raise the likelihood of developing atrial fibrillation, or... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2020 Category: General Medicine Source Type: news

Got A-fib? It Could Heighten COVID Risks
MONDAY, Nov. 9, 2020 -- Two preliminary studies offer mixed news for heart patients who fall ill with COVID-19: Those on certain blood pressure-lowering drugs are not at increased risk of dying, but those with atrial fibrillation (a-fib) may be. In... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2020 Category: General Medicine Source Type: news

Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
RARITAN, N.J., November 5, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today more than 35 company-sponsored studies, including 10 oral presentations, will be featured at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition taking place virtually December 5-8, 2020.In multiple myeloma, highlights include Phase 1b/2 results for the B-cell maturation antigen (BCMA)-targeted chimeric antigen receptor T-cell (CAR-T) therapy ciltacabtagene autoleucel (cilta-cel); new and updated data for the anti-CD38 monoclonal antibody DARZALEX® (daratumumab) and the subcutane...
Source: Johnson and Johnson - November 5, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

VENUS: Vein of Marshall Ethanol Infusion for AF Now Published VENUS: Vein of Marshall Ethanol Infusion for AF Now Published
The trial showed that adding an ethanol infusion to the vein of Marshall during catheter ablation of persistent atrial fibrillation increases the chances of maintaining normal rhythm.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 4, 2020 Category: Cardiology Tags: Cardiology News Source Type: news

CVDPREVENT: A national primary care audit
CVDprevent is a national primary care audit to support professionally led quality improvement in the diagnosis and management of six high risk conditions that cause stroke, heart attack and dementia: atrial fibrillation (AF), high blood pressure, high cholesterol, diabetes, non-diabetic hyperglycaemia and chronic kidney disease. (Source: NHS Networks)
Source: NHS Networks - October 30, 2020 Category: UK Health Source Type: news

Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX(TM) Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., Oct. 29, 2020 -- (Healthcare Sales & Marketing Network) -- Boston Scientific Corporatio... Devices, Interventional, Cardiology Boston Scientific, WATCHMAN FLX, Left Atrial Appendage, atrial fibrillation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 29, 2020 Category: Pharmaceuticals Source Type: news

Large Babies Could Be at Risk for Later Atrial Fibrillation
WEDNESDAY, Oct. 28, 2020 -- There may be a positive causal relationship between elevated birth weight and risk for future atrial fibrillation in adulthood, according to a study presented at the annual Great Wall International Congress of Cardiology,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 28, 2020 Category: Pharmaceuticals Source Type: news

Shot of alcohol can help an irregular heartbeat
(Houston Methodist) Research out in this week's issue of JAMA confirms the success of a treatment for persistent atrial fibrillation (AFib) that combines the standard treatment, catheter ablation, with a separate infusion of ethanol, or alcohol, to the vein of Marshall. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 28, 2020 Category: International Medicine & Public Health Source Type: news

Janssen Submits Application to U.S. FDA for New Indication to Expand Use of XARELTO ® (rivaroxaban) in Patients with Peripheral Artery Disease
RARITAN, NJ, October 26, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today it has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for a new indication to expand the use of XARELTO® (rivaroxaban) in patients with peripheral artery disease (PAD). If approved, this new indication for the XARELTO® vascular dose (2.5 mg twice daily plus aspirin 75-100 mg once daily) would include reducing the risk of major thrombotic vascular events such as heart attack, stroke and amputation in patients after recent lower-extremity revasculariz...
Source: Johnson and Johnson - October 26, 2020 Category: Pharmaceuticals Tags: Innovation Source Type: news

New model predicts which patients with kidney disease may develop heartbeat irregularities
(American Society of Nephrology) * A new model that incorporates a type of artificial intelligence can accurately predict which individuals with chronic kidney disease face a high risk of developing atrial fibrillation.* Results from the study will be presented online during ASN Kidney Week 2020 Reimagined October 19-October 25. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 24, 2020 Category: International Medicine & Public Health Source Type: news

Use of anticoagulants in patients with non-valvular atrial fibrillation who are at risk of falls - Shanah L, Kabashneh S, Alkassis S, Ali H, Mir T.
Atrial fibrillation (AF) is a relatively common clinical entity with significant morbidity and mortality, particularly in the elderly. Stroke is  one of the most significant complications of AF, which can be prevented with the use of anticoagulation. Elder... (Source: SafetyLit)
Source: SafetyLit - October 22, 2020 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Seeking quick, inhaled fix for irregular heartbeats, Newark company drums up $30M
InCarda hopes to makes its drug-device available for atrial fibrillation patients to use at home, but it still must wait for two key late-stage clinical trials and more cash. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 21, 2020 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Seeking quick, inhaled fix for irregular heartbeats, Newark company drums up $30M
InCarda hopes to makes its drug-device available for atrial fibrillation patients to use at home, but it still must wait for two key late-stage clinical trials and more cash. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - October 21, 2020 Category: Biotechnology Authors: Ron Leuty Source Type: news

Big Babies May Face Higher Lifelong A-Fib Risk
MONDAY, Oct. 19, 2020 -- Parents are usually pleased when their newborn seems big and strong, but new research suggests that large babies may be at higher risk for the heart rhythm disorder atrial fibrillation later in life. Atrial fibrillation... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 19, 2020 Category: General Medicine Source Type: news

Big babies could be at higher risk of common heart rhythm disorder in adulthood
(European Society of Cardiology) Elevated birth weight is linked with developing atrial fibrillation later in life, according to research presented at the 31st Great Wall International Congress of Cardiology (GW-ICC). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 18, 2020 Category: International Medicine & Public Health Source Type: news

A-Fib Treatment Reduces Patients' Dementia Risk
WEDNESDAY, Oct. 14, 2020 -- A procedure to restore normal heart rhythm is more effective than medications in reducing dementia risk in people with the heart rhythm disorder atrial fibrillation (AF), researchers report. Previous studies have shown... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 14, 2020 Category: General Medicine Source Type: news

New-Onset Atrial Fibrillation in Sepsis: A Narrative Review
Atrial fibrillation (AF) is a frequently identified arrhythmia during the course of sepsis. The aim of this narrative review is to assess the characteristics of patients with new-onset AF related to sepsis and the risk of stroke and death, to understand if there is a need for anticoagulation. We searched for studies on AF and sepsis on PubMed, the Cochrane database, and Web of Science, and 17 studies were included. The mean incidence of new-onset AF in patients with sepsis was 20.6% (14.7% in retrospective studies and 31.6% in prospective). Risk factors for new-onset AF included advanced age, white race, male sex, obesity,...
Source: Current Awareness Service for Health (CASH) - October 9, 2020 Category: Consumer Health News Source Type: news